alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 22

- 6655

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,

v. JUSTIN DEONTA STROM, a/k/a Jae Dee, a/k/a Jae, a/k/a J

- Dirt , Defendant

- Appellant

.

No. 22

- 6850

UNITED STATES OF AMERICA , Plaintiff

- Appellee ,

v. JUSTIN DEONTA STROM, a/k/a Jae Dee, a/k/a Jae, a/k/a J

- Dirt , Defendant

- Appellant.

Appeal s from the United States District Court for the Eastern District of Virginia , at Alexandria

. Leonie M. Brinkema , District Judge. ( 1:12

- cr - 00159

- LMB

- 1 )

Submitted : December 15, 2022 Decided: December 20, 2022 USCA4 Appeal: 22-6655 Doc: 6 Filed: 12/20/2022 Pg: 1 of 32 Before GREGORY, Chief Judge , and WILKINSON and DIAZ , Circuit Judges

.

Affirmed by un published per curiam opinion

.
Justin Deonta Strom, Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit. USCA4 Appeal: 22-6655 Doc: 6 Filed: 12/20/2022 Pg: 2 of 33 PER CURIAM: In these consolidated cases, Justin Deonta Strom appeals the district court’s orders denying Strom’s Fed. R. Crim. P. 36 moti ons to correct purported clerical errors in his presentence report and criminal judgment. Upon review of the record, we discern no error in the district court’s rulings on Strom’s motions. Accordingly, we affirm the district
court’s orders. United State s v. Strom , No. 1:12

- cr - 00159

- LMB

- 1 (E.D. Va. May 24, 2022 ; July 14, 2022). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional proces s.
AFFIRMED USCA4 Appeal: 22-6655 Doc: 6 Filed: 12/20/2022 Pg: 3 of 3
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

CASE NO. 3:17-cv-00939-WHA

WAYMO’S RESPONSE TO NON-PARTY LEVANDOWSKI’S MOTION FOR INTERVENTION

QUINN EMANUEL URQUHART & SULLIVAN, LLP 

 Charles K. Verhoeven (Bar No. 170151) 

 charlesverhoeven@quinnemanuel.com 

 David A. Perlson (Bar No. 209502) 

 davidperlson@quinnemanuel.com 

 Melissa Baily (Bar No. 237649) 

 melissabaily@quinnemanuel.com 

 John Neukom (Bar No. 275887) 

 johnneukom@quinnemanuel.com 

 Jordan Jaffe (Bar No. 254886) 

 jordanjaffe@quinnemanuel.com 

50 California Street, 22nd Floor 

San Francisco, California 94111-4788 

Telephone: (415) 875-6600 

Facsimile: (415) 875-6700 

Attorneys for WAYMO LLC 

UNITED STATES DISTRICT COURT 

NORTHERN DISTRICT OF CALIFORNIA, SAN FRANCISCO DIVISION 

WAYMO LLC, 

Plaintiff, 

vs. 

UBER TECHNOLOGIES, INC.; 

OTTOMOTTO LLC; OTTO TRUCKING 

LLC, 

Defendants. 

CASE NO. 3:17-cv-00939-WHA 

PLAINTIFF WAYMO’S RESPONSE TO 

NON-PARTY ANTHONY 

LEVANDOWSKI’S MOTION FOR 

INTERVENTION UNDER RULE 24(b) 

Date: To be set by the Court 

Time: To be set by the Court 

Courtroom: The Hon. William H. Alsup, 

Courtroom 8, 19th Floor 

Case 3:17-cv-00939-WHA Document 162 Filed 04/05/17 Page 1 of 2
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

-1- CASE NO. 3:17-cv-00939-WHA

WAYMO’S RESPONSE TO NON-PARTY LEVANDOWSKI’S MOTION FOR INTERVENTION

Plaintiff Waymo LLC (“Waymo”) hereby responds to the Court’s Order (Dkt. 153) 

requiring a response to Non-Party Anthony Levandowski’s Motion for Intervention Under Rule 

24(b). (Dkt. 151.) The relief that non-party Anthony Levandowski seeks by intervening in this 

case is without merit for all of the reasons stated in Waymo’s Opposition to Non-Party Anthony 

Levandowski’s Motion for Modification of the Court’s Order Dated March 16, 2017. (Dkt. 

159.) Nevertheless, Waymo does not oppose Anthony Levandowski’s motion for permissive 

intervention for the sole purpose of litigating his Motion for an Order Modifying the Court’s 

March 16, 2017 Order. (Dkt. 147.) To the extent Mr. Levandowski’s requested intervention is 

broader than this request (e.g., to delay the case schedule pending any appeal of any ruling by the 

Court or by another means), Waymo respectfully reserves its right to oppose at that time. See Dkt. 

131 (3/28/17 Tr.) at 9:6-7 (making clear that Defendants do not get to “slow this [case] down” 

based on Mr. Levandowski’s assertion of any alleged Fifth Amendment rights.) 

DATED: April 5, 2017 QUINN EMANUEL URQUHART & SULLIVAN, 

LLP 

By /s/ David A. Perlson

David A. Perlson 

Attorneys for WAYMO LLC 

Case 3:17-cv-00939-WHA Document 162 Filed 04/05/17 Page 2 of 2
---

|EXHIBIT 32.2                               
|-------------------------------------------
|                                           
|                                           
|CERTIFICATION                              
|PURSUANT TO 18 U.S.C. SECTION 1350         
|AND RULE 13a-14(b) OR RULE 15d-14(b)       
|OF THE U.S. SECURITIES EXCHANGE ACT OF 1934

In connection with the amendment to the Annual Report of EMC
Metals Corp. (the "Company") on Form 10-K/A Amendment No. 3 for the year ended
December 31, 2011 (the "Report"), the undersigned, in the capacities and on the
date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his
knowledge:

| | 1. | The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                                 
| | 2. | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.

|Dated: July 5, 2012 | /s/ Edward
      Dickinson 
|------------------- | ---------------------------
|                    | Edward Dickinson           
|                    | Principal Financial Officer

---
Jamario NOBLES, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D19-2032

District Court of Appeal of Florida, Second District.

July 17, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
NAPOLILAW.COM

360 LEXINGTON AVENUE, 11TH FLOOR, NEW YORK, NEW YORK 10017 | (212) 397-1000

Andrew J. Dressel

Senior Associate and Assistant General Counsel

September 25, 2018

VIA ECF

United States District Court

for the Northern District of California

Hon. William Alsup

450 Golden Gate Avenue

San Francisco, CA 94102

In Re: Martin Dulberg, et al. v. Uber Technologies.et al., Case No. 3:17-cv-00850-WHA

Dear Judge Alsup:

Napoli Shkolnik PLLC represents Plaintiff Martin Dulberg, individually and on behalf of all 

others similarly situated (the “Plaintiffs”) in the above-referenced case. Please be advised that I am 

leaving the firm as of September 28, 2018. As such, I respectfully request that my name be removed 

as the “Attorney to be Noticed” as I am no longer representing the Plaintiff’s in this case. Napoli 

Shkolnik PLLC will remain Plaintiff’s counsel. 

Thank you in advance for your time and attention to this matter. Please do not hesitate to 

contact me if you have any questions.

Sincerely, 

NAPOLI SHKOLNIK PLLC

By: /s/ Andrew J. Dressel

Andrew J. Dressel, Esq.

360 Lexington Avenue, 11th Floor

New York, NY 10017

(212) 397-1000, Ext. 2564

ADressel@NapoliLaw.com

cc: all counsel by ECF

Case 3:17-cv-00850-WHA Document 118 Filed 09/25/18 Page 1 of 2
NAPOLILAW.COM

360 LEXINGTON AVENUE, 11TH FLOOR, NEW YORK, NEW YORK 10017 | (212) 397-1000

CERTIFICATE OF SERVICE

The undersigned attorney hereby certifies that on September 25, 2018, he electronically filed 

a copy of the attached via the CM/ECF filing system, which sent notification of such filing to all 

Filing Users.

/s/ Andrew J. Dressel

Case 3:17-cv-00850-WHA Document 118 Filed 09/25/18 Page 2 of 2
William French ANDERSON, petitioner, v. CALIFORNIA.

No. 12-1001.

Supreme Court of the United States

April 1, 2013.

Petition for writ of certiorari to the Court of Appeal of California, Second Appellate District, denied.
Pour plus d’informations sur l’équité en santé, 

visitez www.fda.gov/healthequity.

DIAGNOSTIC TAUX D’A1C

Normal

Prédiabète

Diabète

Inférieur à 5,7%

De 5,7% à 6,4%

6,5% ou plus

Bureau de la santé des minorités et de l’équité en santé

Le test A1C peut être utilisé pour diagnostiquer ou gérer le 

diabète en mesurant votre glycémie moyenne (taux de sucre 

dans le sang) au cours des trois derniers mois.

Pour la plupart des personnes vivant avec le diabète, un taux 

d'A1C de 7 % ou moins est idéal. Des taux d'A1C plus élevés 

vous exposent à un risque de complications du diabète.

Discutez avec votre prestataire de soins de santé de la 

possibilité de faire un test A1C et de la fréquence qui vous 

convient.

LE TEST A1C POUR LE DIABÈTE 
 LE TEST A1C POUR LE DIABÈTE

Le test A1C peut être utilisé pour diagnostiquer ou gérer le 

diabète en mesurant votre glycémie moyenne (taux de sucre 

dans le sang) au cours des trois derniers mois.

Pour la plupart des personnes vivant avec le diabète, un taux 

d'A1C de 7 % ou moins est idéal. Des taux d'A1C plus élevés

vous exposent à un risque de complications du diabète.

Discutez avec votre prestataire de soins de santé de la 

possibilité de faire un test A1C et de la fréquence qui vous 

convient.

Pour plus d’informations sur l’équité en santé, 

visitez www.fda.gov/healthequity.

DIAGNOSTIC TAUX D’A1C

Normal

Prédiabète

Diabète

Inférieur à 5,7%

De 5,7% à 6,4%

6,5% ou plus

Bureau de la santé des minorités et de l’équité en santé
Pour plus d'informations sur l'équité en santé, 

visitez www.fda.gov/healthequity.

DIAGNOSTIC TAUX D’A1C

Normal

Prédiabète

Diabète

Inférieur à 5,7%

De 5,7% à 6,4%

6,5% ou plus

LE TEST A1C POUR LE DIABÈTE 

Bureau de la santé des minorités et de l’équité en santé

Le test A1C peut être utilisé pour diagnostiquer ou gérer le 

diabète en mesurant votre glycémie moyenne (taux de sucre 

dans le sang) au cours des trois derniers mois.

Pour la plupart des personnes vivant avec le diabète, un taux 

d'A1C de 7 % ou moins est idéal. Des taux d'A1C plus élevés

vous exposent à un risque de complications du diabète.

Discutez avec votre prestataire de soins de santé de la 

possibilité de faire un test A1C et de la fréquence qui vous 

convient.
Exhibit 23.8


Consent of Independent Auditors





The Board of Directors


Kennedy-Wilson Holdings, Inc.:


We consent to the use of our report dated March 31, 2014, with respect to the consolidated statements of operations and comprehensive income, partners’ capital, and cash flows of KWF Real Estate Venture VI, L.P. and subsidiary for the year ended December 31, 2013, and the related notes to the consolidated financial statements, incorporated by reference in the registration statements (No. 333-174742, No. 333-175002, No. 333-175559, No. 333-184752, and No. 333-192059) on Form S-3, the registration statements (No. 333-164928, No. 333-182269, and No. 333-197492) on Form S-8, the registration statement (No. 333-164926) on Form S-1/A and the registration statement (No. 333-186690) on Form S-4 of Kennedy-Wilson Holdings, Inc. in reliance upon the report of KPMG LLP, independent auditors, which report appears in amendment no. 1 to the December 31, 2015 annual report on Form 10-K of Kennedy-Wilson Holdings, Inc.








/s/ KPMG LLP


Los Angeles, California


March 25, 2016
**EXHIBIT        32.1**

**CERTIFICATION        PURSUANT TO**

**18        U.S.C. SECTION 1350**

**AS        ADOPTED PURSUANT TO**

**SECTION        906 OF THE SARBANES-OXLEY ACT OF 2002**

| (1) | The                  Report fully complies with the requirements of Section 13(a) or                  15(d) of                  the Securities Exchange Act of 1934, as amended;                  and |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The                  information contained in the Report fairly presents, in all material                  respects, the financial condition and results of operations of                  the                  Registrant. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|         |                                                                                                                                                                                                             |                                       |
|--------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------|
|         | WATCHTOWER,                  INC.                                                                                                                                                                                |
|    |                                                                                                                                                                                                        |                                  |
|         | By:                                                                                                                                                                                                    | /s/ Yisroel                Guttfreund |
|         | Name:Yisroel                Guttfreund                                                                                                                                                                           |
|         | Title:                    President                  and Chief Executive Officer,Chairman,                  and Director(Principal                  Executive, Financial and Accounting Officer)  |
Filed by Bowne Pure Compliance





Exhibit 10.2




Scott J. Pollei

c/o Dolan Media Company

222 South Ninth Street, Suite 2300

Minneapolis, MN 55402




February 3, 2009




John C. Bergstrom

Chair, Compensation Committee

Dolan Media Company

222 South Ninth Street, Suite 2300

Minneapolis, MN 55402





Re: Waiver of 2009 Base Salary Increase



Dear John:



Reference is made to that certain Amended and Restated Employment Agreement dated effective as
of April 1, 2007, as the same may be amended from time to time, between Dolan Media Company (the
“Company”) and Mark W.C. Stodder (the “Employment Agreement”). Capitalized terms used, but not
otherwise defined, in this letter agreement, shall have the meanings ascribed to such terms in my
Employment Agreement.




Section 2.1 of my Employment Agreement provides, in relevant part:




For the calendar year beginning January 1, 2008, and for each subsequent calendar
year during the Employment Period, the Company will pay Executive a Base Salary
equal to the Base Salary for the previous calendar year increased by the positive
percentage change, if any, in the CPI. . . from the month of December from two
(2) years prior to the month of December from the previous year.



By this letter, I hereby waive my right to the increase in my Base Salary described in Section 2.1
of my Employment Agreement for calendar year 2009. I further acknowledge and agree that my Base
Salary for the calendar year 2009 will be $264,000 until such time as the Compensation Committee
determines, if at all, to award an increase to my Base Salary. Further, if the Compensation
Committee determines to award an increase to my Base Salary at any time in 2009, I hereby authorize
the Compensation Committee to award, in its discretion, an increase in an amount less than the
increase required under Section 2.1 of my Employment Agreement.


 


 









 





The waiver provided here is for the increase due to me under my Employment Agreement for the
calendar year 2009 only and does not constitute a waiver of (a) an increase to my Base Salary for
calendar year 2010 or any subsequent years that my Employment Agreement is in effect or (b) any
other compensation for which I am eligible under my Employment Agreement,
short-term cash incentive plans, or any other Company plans, including the 2007 Incentive Compensation
Plan. I further confirm that my waiver of an increase to my Base Salary for the calendar year 2009
does not constitute a “Good Reason” as defined in my Employment Agreement.



This waiver shall be governed by the laws of the State of Minnesota without reference to its
conflicts of law principles. This waiver may be executed by facsimile or email transmission and in
one or more counterparts, each of which shall constitute an original and which, together, shall
constitute on instrument.



	 	 	 	 	 
	 	Sincerely,

 	 
	 	/s/ Scott J. Pollei
 	 
	 	Scott J. Pollei 	 



	 	 	 
	Acknowledged:
	 	 
	 
	 	 
	DOLAN MEDIA COMPANY
	 	 
	 
	 	 
	/s/ John C. Bergstrom
 

By: John C. Bergstrom

	 	 
	Its: Compensation Committee Chair
아주 좋음 좋음

멸치류

대서양 조기

대서양 고등어

농어

버터피시

메기

대합조개

대구

게

민물가재

도다리 

해덕대구 

메를루사

청어

미국 바닷가재와 닭새우

숭어 

굴

태평양 고등어

퍼치, 민물과 바다 

강꼬치고기

유럽 넙치

명태 

연어 

정어리

가리비

전어 

새우 

홍어 

바다빙어 

가자미 

오징어 

틸라피아

송어, 민물

참치, 라이트 통조림

(가다랑어 포함)

화이트피시

화이팅

블루피시 

버팔로피시 

잉어

칠레 농어/메로

그루퍼

대서양 넙치

마히마히/만새기

아귀 

볼락 

은대구 

양머리돔 

도미

삼치 

줄농어(바다)

옥돔류(대서양) 

참치, 날개다랑어/

흰다랑어, 

통조림과 선어/냉동

참치, 황다랑어

민어/바다송어

흰조기/태평양 조기

피해야 함 수은 함량 최고 수준

동갈삼치류 

청새치

오렌지 러피

상어 

황새치

옥돔류(멕시코만)

참치, 눈다랑어

가족이나 친구가 잡은 생선은 어떻게 할까요? 어패류 섭취 권고 사항을 참고해 해당 생선을 안전하게 섭취할 수 있는 빈도를 확인하십시오. 권고 기준이 없는 경우, 

1회 섭취량만 섭취하고 그 주에 다른 생선은 드시지 마십시오. 대형 잉어, 메기, 송어, 퍼치와 같이 가족이나 친구가 잡은 일부 생선은 수은이나 기타 오염물질로 

인한 섭취 권고가 있을 가능성이 높습니다.

아주 좋음

좋음

피해야 함

수은 함량이 낮은 생선을 선택하십시오.

임신, 모유수중 중 여성과 어린이 식단에서 수은 제한하는 것이 중요한 반면, 영양소가 풍부하면서도 수은 함량이 낮은 

생선도 많이 있습니다.

생선‡은 어린이의 두뇌 발달에 도움이 되는 

핵심 영양소를 제공합니다.

생선 섭취 시 권고 사항

임신 예정, 임신 중, 모유수유 중 또는 1~11세 사이 어린이의 경우

‡ 이 권고 사항은 생선과 조개/갑각류를 총괄하여 “생선”으로 지칭합니다 / 2021년 10월 자 개정 권고 사항

어린이:

평균적으로 1회 섭취량은:

1 온스 - 1~3세

2 온스 - 4~7세

3 온스 - 8~10세

4 온스 - 11세

“아주 좋음” 목록에서 1주일에 2회 섭취량을 섭취하십시오.

1회 섭취량이란? 손바닥을 가이드로 사용하십시오.

임신 및 모유수유 시:

1회 섭취량은 4온스

“아주 좋음” 목록에서 1주일에 

2~3회 섭취량을 섭취하십시오

(또는“좋음” 목록에서 1회 섭취량).

아래 표는 수은 함량을 바탕으로 어떤 생선을 먹고 얼마나 자주 먹어야 할지 결정하는 데 도움이 될 수 있습니다.

생선 섭취는 건강한 식습관에 해당되며 임신, 모유수유 및/또는 초기 아동기에 다음과 같이 

아동 두뇌 발달에 도움을 주는 핵심 영양소를 제공합니다.

• 오메가-3(DHA 및 EPA) 및 오메가-6 지방

• 철분

• 요오드(임신 중)

• 콜린

콜린은 아기의 척수 발달에도 도움을 줍니다. 생선은 아동 면역계에 도움을 주는 철분과 아연을 

제공합니다. 그밖에도 생선은 단백질, 비타민 B12, 비타민 D와 셀레늄과 같은 영양소의 공급원입니다.

www.FDA.gov/fishadvice

www.EPA.gov/fishadvice
건강한 식습관은 모든 식품군

(채소류, 과일류, 곡류, 유제품, 

그리고 생선을 포함한 단백질 

식품)을 골고루 선택해 칼로리 

필요량 이내에서 권장량을 

섭취하는 것입니다. 건강한 

식습관에는 비타민, 미네랄 

및 기타 건강 촉진 요소가 

포함되며 당, 포화지방, 

나트륨은 전혀 가하지 않거나 

거의 가하지 않아야 합니다.

생선을 섭취하면 다른 좋은 점도 있습니다.

뼈 건강 촉진 – 고관절 골절의 위험성을 낮춰줌*

과체중이나 비만이 될 위험성을 낮춰줌*

대장암(결장암 및 직장암)의 위험성을 낮춰줌*

미국인을 위한 식생활 가이드라인에서는 건강한 

식습관의 일부로서 생선 섭취를 권장합니다.

미국인을 위한 식생활 가이드라인의 권장 사항은 아래와 같습니다.

• 2,000칼로리 식단을 기준으로 주당 최소한 8온스의 해산물(아동의 경우 더 적은 양§).

• 임신 중이거나 모유수유 중인 여성은 수은 함량이 낮은 다양한 해산물을 주당 

8~12온스 사이에서 섭취하십시오.

이 권고 사항은 미국인을 위한 식생활 가이드라인(Dietary Guidelines for Americans)의 권장 사항을 뒷받침하며, 이는 공중 보건을 증진하기 위한 영양에 

관한 현재의 과학 내용을 반영합니다. 미국인을 위한 식생활 가이드라인은 식습관과 건강에 대한 식품과 영양소 특성의 영향에 초점을 맞춥니다.

§ 일부 아동의 경우, 미국인을 위한 식생활 가이드라인의 생선 권장량이 이 FDA/EPA 권고 사항보다 더 높습니다. 미국인을 위한 식생활 가이드라인에서는 

이 더 높은 권장량을 섭취하기 위해서, 아동에게는 수은 함량이 훨씬 더 낮은 “아주 좋음” 목록의 생선만 먹일 것을 말하고 있습니다 - 이러한 생선으로는 

멸치류, 대서양 고등어, 메기, 대합조기, 게, 민물가재, 도다리, 해덕대구, 숭어, 굴, 유럽 넙치, 명태, 연어, 정어리, 가리비, 전어, 새우, 가자미, 오징어, 

틸라피아, 송어와 화이팅 등이 있습니다.

* 전반적인 식습관과 잠재적인 건강 혜택 사이에는 유관한 관계가 있다는 적지 않은 과학적인 증거가 존재합니다.

‡ 이 권고 사항은 생선과 조개/갑각류를 총괄하여 “생선”으로 지칭합니다 / 2021년 10월 자 개정 권고 사항

계속

생선 섭취 시 권고 사항

임신 예정, 임신 중, 모유수유 중 또는 1~11세 사이 어린이의 경우

www.FDA.gov/fishadvice	 www.EPA.gov/fishad

아기의 인지 발달에 도움을 줄 수 있다는 과학적인 증거로 보아 임신 중에 생선 섭취를 

권장합니다.

건강한 식습관의 일부로 생선을 섭취하면 심장 건강에 도움이 될 수 있다는 탄탄한 

과학적 증거가 존재합니다. 생선을 포함하는 건강한 식습관에는 다른 장점도 있습니다. 

생선 섭취량이 상대적으로 높으면서 채소, 과일, 콩, 통곡물, 저지방 또는 무지방 유제품, 

지방이 적은 육류와 가금류, 견과류 및 불포화 식물 기름이 풍부하고 붉은 고기와 가공육, 

가당 식품 및 음료, 그리고 정제된 곡류 섭취량은 낮은 식습관의 경우 다음과 연관이 

있다는 적지 않은 과학적 증거가 존재합니다.
IV 

118TH CONGRESS 

1ST SESSION H. CON. RES. 14 

Expressing disapproval of the revocation by President Biden of the 

Presidential permit for the Keystone XL pipeline. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 7, 2023 

Mrs. LESKO (for herself and Mr. BALDERSON) submitted the following concurrent resolution; which was referred to the Committee on Transportation 

and Infrastructure, and in addition to the Committees on Energy and 

Commerce, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions 

as fall within the jurisdiction of the committee concerned 

CONCURRENT RESOLUTION 

Expressing disapproval of the revocation by President Biden 

of the Presidential permit for the Keystone XL pipeline. 

Whereas, on March 29, 2019, TransCanada Keystone Pipeline, L.P., was granted a Presidential permit to construct, connect, operate, and maintain the Keystone XL 

pipeline; and 

Whereas, on January 20, 2021, President Biden issued Executive Order 13990 (86 Fed. Reg. 7037) that revoked the 

March 2019 Presidential permit for the Keystone XL 

pipeline: Now, therefore, be it 

1 Resolved by the House of Representatives (the Senate 

2 concurring), That Congress disapproves of the revocation 


pbinns on DSKJLVW7X2PROD with $$_JOB
2 

•HCON 14 IH 

1 by President Biden of the Presidential permit for the Key2 stone XL pipeline. 

Æ 


pbinns on DSKJLVW7X2PROD with $$_JOB